...
首页> 外文期刊>Russian Journal of General Chemistry >Synthesis and Antitumor Activity of Some New Fused Heterocyclic Compounds
【24h】

Synthesis and Antitumor Activity of Some New Fused Heterocyclic Compounds

机译:一些新的稠合杂环化合物的合成与抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

Reaction of thiopyrimidine derivative 3 with hydrozonoyl chlorides 4a-4e gives new fused heterocyclic compounds 7a-7e containing triazole ring. The latter demonstrates a wide range of biological activities. Thiazolone pyridopyrimidines 8, 9a, 9b are prepared by the reaction of thiopyrimidines with chloroacetic acid and different aromatic aldehydes in the presence of acetic anhydride. Bis-arylidene 2 reacts with malononitrile or ethyl cyanoacetate with formation of carbonitrile derivatives 10, 11. Reaction of bisarylidene 2 with phenyl hydrazine and hydrazine hydrate leads to diazole derivatives 12, 13. Structures of the new compounds are elucidated from IR, H-1 and C-13 NMR, and mass spectra. All newly synthesized products are tested for antitumor activity on three human tumor cell lines, including prostatic adenocarcinoma (PC3), human colorectal carcinoma (HCT116), human liver hepatocellular carcinoma (HepG2) and breast carcinoma (MCF7). Compounds 2, 7a-7d demonstrate the considerable potency.
机译:硫嘧啶衍生物3与羟基酰氯4a-4e的反应给出了含有三唑环的新的稠合杂环化合物7a-7e。后者展示了广泛的生物活动。通过在乙酸酐存在下,通过硫嘧啶与氯乙酸和不同芳族醛的反应来制备噻唑酮吡啶吡啶酰胺8,9a,9b。双亚亚亚芳基2与碳腈衍生物的形成反应,11。双芳基甲苯二甲苯二甲苯肼和肼水合物的反应导致二唑衍生物12,13。从IR,H-1阐明新化合物的结构和C-13 NMR和质谱。所有新合成的产品都在三种人肿瘤细胞系上进行抗肿瘤活性测试,包括前列腺腺癌(PC3),人结肠癌(HCT116),人肝肝细胞癌(HEPG2)和乳腺癌(MCF7)。化合物2,7a-7d表现出相当大的效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号